Enalapril Maleate
Who holds supplier records for Enalapril Maleate? 8 organisations hold a current record for Enalapril Maleate: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Spain (2) and China (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Enalapril Maleate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/enalapril-maleate
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Enalapril Maleate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Neuland Laboratories LimitedIndiaCEPActive DMF 15434, 19984, 43618 · latest filing Feb 2026
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 13836 · latest filing Nov 1998
- FARMHISPANIA SASpainCEPActive DMF 11525 · latest filing May 1995
- SRI KRISHNA PHARMACEUTICALS LTDIndiaCEP Company GMP cert on recordActive DMF 40211 · latest filing Jul 2024
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 14355 · latest filing Jun 1999
- SpainCEP
- Zhejiang Changming Pharmaceutical Co.,LtdChinaCEP
- KRKA DD NOVO MESTOCEPInactive DMF 12809 · latest filing Dec 1997
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Enalapril Maleate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SRI KRISHNA PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2022-175 - Rev 01 Enalapril maleate, Process-II | Oct 2026 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2024-245 - Rev 02 Enalapril maleate, Process II | Jun 2026 | — |
| ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2009-367 - Rev 03 Enalapril maleate | May 2025 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2000-053 - Rev 07 Enalapril maleate | Nov 2023 | Inspected May 2026 Italy |
| INKE, S.A. Castellbisbal | ES | R1-CEP 2000-070 - Rev 04 Enalapril maleate | Feb 2019 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2002-076 - Rev 05 Enalapril maleate | Aug 2018 | — |
| Farmhispania, S.A. Montmeló | ES | R1-CEP 2006-104 - Rev 01 Enalapril maleate | Mar 2013 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | R1-CEP 2000-212 - Rev 02 Enalapril maleate | Sept 2010 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Enalapril Maleate are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- Argentina · Inactive DMF 11656, 20317 · filed Mar 2007
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 19058 · filed Dec 2005
- PHARMACEUTICAL WORKS POLPHARMA SAInactive DMF 18950 · filed Nov 2005
- CHEMSOURCE CORPInactive DMF 14938 · filed Jun 2000
- India · Inactive DMF 13820 · filed Nov 1998
- Spain · Inactive DMF 13055 · filed Jun 1998
- Hungary · Inactive DMF 12939 · filed Apr 1998
- India · Inactive DMF 12780 · filed Dec 1997
- ESTEVE QUIMICA SAInactive DMF 11866 · filed Feb 1996
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Enalapril Maleate is an angiotensin-converting enzyme (ACE) inhibitor used in the treatment of hypertension and congestive heart failure. It reduces blood pressure and enhances survival in patients with heart failure.
Chemical identity
- IUPAC name
- (Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
- Canonical SMILES
- CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O.C(=C\C(=O)O)\C(=O)O
- InChIKey
- OYFJQPXVCSSHAI-QFPUQLAESA-N
- Synonyms
- Vasotec API, amprace, cardiovet, enacard, enapren, epaned, glioten, hipoartel, innovace, lexxel component enalapril maleate, mk-421, naprilene
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
- Mechanism of action
- Angiotensin-converting Enzyme Inhibitors
- Physiologic effect
- Decreased Blood Pressure
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Enalapril Maleate?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Enalapril Maleate: Neuland Laboratories Limited (India), Dr. Reddy's Laboratories Ltd. (India), FARMHISPANIA SA (Spain), SRI KRISHNA PHARMACEUTICALS LTD (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), INKE SA (Spain), Zhejiang Changming Pharmaceutical Co.,Ltd (China) and KRKA DD NOVO MESTO. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Enalapril Maleate Drug Master Files are active?
Neuland Laboratories Limited (DMF 15434, 19984), Dr. Reddy's Laboratories Ltd. (DMF 13836), FARMHISPANIA SA (DMF 11525), SRI KRISHNA PHARMACEUTICALS LTD (DMF 40211) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 14355). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Enalapril Maleate records mean?
9 organisations have only inactive Type II DMFs for Enalapril Maleate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Enalapril Maleate have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Enalapril Maleate on the EDQM register, including SRI KRISHNA PHARMACEUTICALS LIMITED Hyderabad (IN), NEULAND LABORATORIES LIMITED Hyderabad (IN), ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Taizhou (CN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai (CN), INKE, S.A. Castellbisbal (ES) and DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Enalapril Maleate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Enalapril Maleate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.